Tyber Medical, an orthopedic and spine device company, received the CE Mark approval for TyPEEK, a proprietary titanium plasma sprayed PEEK interbody system designed for situations when PEEK alone may not provide the best setting for fusion.
DFINE, a spine device company, has received the CE Mark approval for the STAR Tumor Ablation System for treating painful metastatic spinal tumors.
The first clinical use of Biomet’s Signature Patient Specific glenoid instrumentation in the United States has been successful.
Invibio Biomaterial Solutions has launched the PEEK-OPTIMA HA Enhanced Polymer, a combination of the PEEK-based biomaterial and Hydroxyapatite, an osteoconductive material.
Flower Orthopedics has made the FlowerCube, a standardized, single-use bone fixation concept that provides operation and operational efficiencies, available.
The first human implantation of Alachua, Fla.-based RTI Surgical’s map3 Cellular Allogeneic Bone Graft took place last week.
More Articles on Devices:
Indiana Spine Group’s Dr. Kenneth Renkens Comments on Homeostasis Clinical Trial
InVivoLink Raises $1.85M From Private Equity Offering
Medtronic Gains 10% in Q1, Posts $953M Net Earnings
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
